Elevated admission glucose and mortality in patients with acute pulmonary embolism.

Détails

Ressource 1Télécharger: 22074725_BIB_E687059B457E.pdf (133.87 [Ko])
Etat: Public
Version: Final published version
ID Serval
serval:BIB_E687059B457E
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Elevated admission glucose and mortality in patients with acute pulmonary embolism.
Périodique
Diabetes care
Auteur(s)
Scherz N., Labarère J., Aujesky D., Méan M.
ISSN
1935-5548 (Electronic)
ISSN-L
0149-5992
Statut éditorial
Publié
Date de publication
01/2012
Volume
35
Numéro
1
Pages
25-31
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
Although associated with adverse outcomes in other cardiopulmonary conditions, the prognostic value of elevated glucose in patients with acute pulmonary embolism (PE) is unknown. We sought to examine the association between glucose levels and mortality and hospital readmission rates for patients with PE.
We evaluated 13,621 patient discharges with a primary diagnosis of PE from 185 acute care hospitals in Pennsylvania (from January 2000 to November 2002). Admission glucose levels were analyzed as a categorical variable (≤110, >110-140, >140-170, >170-240, and >240 mg/dL). The outcomes were 30-day all-cause mortality and hospital readmission. We used random-intercept logistic regression to assess the independent association between admission glucose levels and mortality and hospital readmission, adjusting for patient (age, sex, race, insurance, comorbid conditions, severity of illness, laboratory parameters, and thrombolysis) and hospital (region, size, and teaching status) factors.
Elevated glucose (>110 mg/dL) was present in 8,666 (63.6%) patients. Patients with a glucose level ≤110, >110-140, >140-170, >170-240, and >240 mg/dL had a 30-day mortality of 5.6, 8.4, 12.0, 15.6, and 18.3%, respectively (P < 0.001). Compared with patients with a glucose level ≤110 mg/dL, the adjusted odds of dying were greater for patients with a glucose level >110-140 (odds ratio 1.19 [95% CI 1.00-1.42]), >140-170 (1.44 [1.17-1.77]), >170-240 (1.54 [1.26-1.90]), and >240 mg/dL (1.60 [1.26-2.03]), with no difference in the odds of hospital readmission.
In patients with acute PE, elevated admission glucose is common and independently associated with short-term mortality.

Mots-clé
Aged, Blood Glucose/metabolism, Diabetes Mellitus/mortality, Female, Hospitalization, Humans, Hyperglycemia/mortality, Kaplan-Meier Estimate, Male, Middle Aged, Patient Readmission, Pennsylvania/epidemiology, Pulmonary Embolism/mortality
Pubmed
Open Access
Oui
Création de la notice
06/01/2017 8:39
Dernière modification de la notice
20/08/2019 16:09
Données d'usage